Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
0.6698
-0.0110 (-1.62%)
At close: Apr 1, 2025, 4:00 PM
0.6626
-0.0072 (-1.08%)
After-hours: Apr 1, 2025, 4:38 PM EDT
Palisade Bio Stock Forecast
PALI's stock price has decreased by -88.74% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Palisade Bio stock have an average target of 23, with a low estimate of 8.00 and a high estimate of 38. The average target predicts an increase of 3,333.86% from the current stock price of 0.67.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 20, 2024.
Analyst Ratings
The average analyst rating for Palisade Bio stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Brookline Capital | Brookline Capital | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +5,573.34% | Nov 20, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $23 → $8 | Strong Buy | Maintains | $23 → $8 | +1,094.39% | Nov 13, 2024 |
| Maxim Group | Maxim Group | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +3,259.21% | May 1, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +3,259.21% | Apr 16, 2024 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $23 | Hold → Strong Buy | Upgrades | $23 | +3,259.21% | Nov 17, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.98
from -10.19
EPS Next Year
-2.88
from -2.98
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.51 | -1.07 | -1.06 | ||
| Avg | -2.98 | -2.88 | -3.60 | ||
| Low | -5.34 | -6.09 | -7.39 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.